Age as a Prognostic Factor in Patients with Localized Melanoma and Regional Metastases
Charles M. Balch(The University of Texas MD Anderson Cancer Center), Vernon K. Sondak(Advanced Dermatology), Daniel G. Coit(Memorial Sloan Kettering Cancer Center), Keith T. Flaherty(Cancer Research Center), Martín C. Mihm(Harvard University), John F. Thompson(Melanoma Institute Australia), Merrick I. Ross(Johns Hopkins University), Michael B. Atkins(Georgetown University), Alexander M.M. Eggermont(University Medical Center Utrecht), Stanley P. L. Leong(California Pacific Medical Center), Jeffrey E. Gershenwald(The University of Texas MD Anderson Cancer Center), Kelly M. McMasters(University of Louisville), Timothy M. Johnson(University of Michigan), Donald L. Morton(University of California, Los Angeles), Seng-Jaw Soong(Johns Hopkins University), Alistair J. Cochran(Western Infirmary), John M. Kirkwood(UPMC Hillman Cancer Center), Shouluan Ding(Johns Hopkins University), Phyllis A. Gimotty(University of Pennsylvania)
Cited by 177
Related Papers
Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
|New England Journal of Medicine|2012|12.6k
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
|New England Journal of Medicine|2011|7.7k
Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq
|Science|2016|5.3k
Final Version of 2009 AJCC Melanoma Staging and Classification
|Journal of Clinical Oncology|2009|4.6k